10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus



Status:Recruiting
Conditions:Psoriasis, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:2 - 17
Updated:12/14/2017
Start Date:June 27, 2005
End Date:December 2026
Contact:Valeant Pharmaceuticals
Phone:908-927-1400

Use our guide to learn which trials are right for you!

A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)

This study will examine the risk of systemic malignancies in pediatric patients with atopic
dermatitis exposed to Elidel 1% cream.

Registry study to examine the risk of systemic malignancies in pediatric patients with atopic
dermatitis exposed to Elidel 1% cream.

Inclusion Criteria:

- males and females

- greater than or equal to 2 years and less than or equal to 17 years at enrollment

- diagnosis of atopic dermatitis (confirmed by treating physician)

- applied pimecrolimus cream 1 % 6 weeks out of past 24 weeks

Exclusion Criteria:

- past or present history of systemic malignancy, skin malignancy, or
lymphoproliferative disease

- past or present use of oral immunosuppressive therapy
We found this trial at
1
site
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials